scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...882283P |
P356 | DOI | 10.1371/JOURNAL.PONE.0082283 |
P932 | PMC publication ID | 3857251 |
P698 | PubMed publication ID | 24349246 |
P5875 | ResearchGate publication ID | 262045815 |
P50 | author | Robert MacLaren | Q27537201 |
Irene Rodríguez-Hernández | Q87342354 | ||
José-Carlos Pastor | Q87896715 | ||
Rogelio Gonzalez-Sarmiento | Q89728620 | ||
Amândio A Rocha-Sousa | Q55168467 | ||
Itziar Fernández | Q56440402 | ||
P2093 | author name string | Salvador Pastor-Idoate | |
Jimena Rojas | |||
José M Ruiz-Moreno | |||
Steven Harsum | |||
David Charteris | |||
Genetics on PVR Study Group | |||
Jan C VanMeurs | |||
María T García-Gutiérrez | |||
Yashin Ramkissoon | |||
P2860 | cites work | A new look at the statistical model identification | Q26778401 |
Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy | Q68178279 | ||
Retinal wound healing. Cellular activity at the vitreoretinal interface | Q70011862 | ||
The classification of retinal detachment with proliferative vitreoretinopathy | Q71748348 | ||
Apoptotic photoreceptor degeneration in experimental retinal detachment | Q72190360 | ||
Proliferative vitreoretinopathy: an overview | Q77144020 | ||
The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation | Q80050309 | ||
Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening | Q83298628 | ||
Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study | Q83355824 | ||
Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome | Q84586158 | ||
The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project | Q85599752 | ||
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy. | Q49030836 | ||
Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment. | Q54611978 | ||
Multiplex Bead Analysis of Vitreous Humor of Patients with Vitreoretinal Disorders | Q60207394 | ||
An updated classification of retinal detachment with proliferative vitreoretinopathy | Q67938098 | ||
Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1 | Q68140147 | ||
Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2 | Q68140150 | ||
Definition and clinical importance of haplotypes | Q28303291 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy | Q28361127 | ||
The MDM2-p53 interaction. | Q34288001 | ||
Proliferative vitreoretinopathy: risk factors and pathobiology | Q34572836 | ||
Inhibition of Mdm2 sensitizes human retinal pigment epithelial cells to apoptosis | Q35027581 | ||
Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a | Q35050530 | ||
TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients | Q35206102 | ||
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck | Q35448964 | ||
MDM2, an introduction. | Q35621040 | ||
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration | Q36015882 | ||
A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect | Q36182593 | ||
A novel function of p53: a gatekeeper of retinal detachment | Q36204186 | ||
The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells | Q36353215 | ||
Gene-environment interactions for complex traits: definitions, methodological requirements and challenges | Q37181708 | ||
Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease | Q37315556 | ||
Apoptosis and other cell death mechanisms after retinal detachment: implications for photoreceptor rescue | Q37903606 | ||
Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. | Q38050745 | ||
Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment | Q39775887 | ||
Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model | Q40132971 | ||
Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice | Q40531865 | ||
The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia | Q40840934 | ||
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome | Q42734774 | ||
A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project. | Q42955616 | ||
Growth factors in proliferative vitreoretinopathy | Q43094987 | ||
Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy | Q44052727 | ||
Ischemic preconditioning attenuates apoptotic cell death in the rat retina | Q44119136 | ||
HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR. | Q44261183 | ||
Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis | Q44956270 | ||
Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy | Q45173867 | ||
A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy | Q45175644 | ||
Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. | Q45221978 | ||
Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. | Q46006684 | ||
Photoreceptor apoptosis in human retinal detachment. | Q46419938 | ||
Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy | Q46425636 | ||
The impact of tacrolimus on growth factors in experimental proliferative vitreoretinopathy | Q46455363 | ||
Non-complicated retinal detachment management: variations in 4 years. Retina 1 project; report 1. | Q46796771 | ||
Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells. | Q47272769 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | risk factor | Q1475848 |
P304 | page(s) | e82283 | |
P577 | publication date | 2013-12-09 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy | |
P478 | volume | 8 |
Q92797443 | Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells |
Q55110302 | Comparison of SNP Genotypes Related to Proliferative Vitreoretinopathy (PVR) across Slovenian and European Subpopulations. |
Q41848097 | Curcumin inhibits human retinal pigment epithelial cell proliferation |
Q33991982 | Developments in Ocular Genetics: 2013 Annual Review |
Q38701296 | Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project |
Q53226854 | Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population. |
Q42380716 | Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy |
Q39166181 | PDGFs and their receptors |
Q37152868 | Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases. |
Q39720539 | The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells |
Q34429965 | Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy |
Search more.